The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Muscle Rigidity

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Muscle Rigidity


Psychiatry related information on Muscle Rigidity


High impact information on Muscle Rigidity


Chemical compound and disease context of Muscle Rigidity


Biological context of Muscle Rigidity


Anatomical context of Muscle Rigidity


Gene context of Muscle Rigidity


Analytical, diagnostic and therapeutic context of Muscle Rigidity


  1. Oxidative stress and antioxidant therapy in Parkinson's disease. Ebadi, M., Srinivasan, S.K., Baxi, M.D. Prog. Neurobiol. (1996) [Pubmed]
  2. A rat model of spontaneous myopathy and malignant hyperthermia. Gonzalez, L.E., Meléndez-Vásquez, C.V., Gregson, N.A., File, S.E. Am. J. Pathol. (1998) [Pubmed]
  3. Neuroleptic malignant syndrome and dopaminergic blockade. Hashimoto, F., Sherman, C.B., Jeffery, W.H. Arch. Intern. Med. (1984) [Pubmed]
  4. Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings? Askmark, H., Eeg-Olofsson, K., Johansson, A., Nilsson, P., Olsson, Y., Aquilonius, S. Arch. Neurol. (2001) [Pubmed]
  5. Predictability of phenotype in Huntington's disease. Farrer, L.A., Conneally, P.M. Arch. Neurol. (1987) [Pubmed]
  6. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. Antkiewicz-Michaluk, L., Michaluk, J., Mokrosz, M., Romanska, I., Lorenc-Koci, E., Ohta, S., Vetulani, J. J. Neurochem. (2001) [Pubmed]
  7. Unequal mitotic sister chromatid exchange and different length of Y chromosomes. Wahlström, J., Kyllerman, M., Hansson, A., Taranger, J. Hum. Genet. (1985) [Pubmed]
  8. Symptomatic Mycobacterium avium complex infection of the central nervous system. A case report and review of the literature. Gyure, K.A., Prayson, R.A., Estes, M.L., Hall, G.S. Arch. Pathol. Lab. Med. (1995) [Pubmed]
  9. Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients. Crowley, T.J., Hoehn, M.M., Rutledge, C.O., Stallings, M.A., Heaton, R.K., Sundell, S., Stilson, D. Arch. Gen. Psychiatry (1978) [Pubmed]
  10. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Klockgether, T., Turski, L., Honoré, T., Zhang, Z.M., Gash, D.M., Kurlan, R., Greenamyre, J.T. Ann. Neurol. (1991) [Pubmed]
  11. Fyn is required for haloperidol-induced catalepsy in mice. Hattori, K., Uchino, S., Isosaka, T., Maekawa, M., Iyo, M., Sato, T., Kohsaka, S., Yagi, T., Yuasa, S. J. Biol. Chem. (2006) [Pubmed]
  12. The neuroleptic malignant syndrome and acute renal failure. Becker, B.N., Ismail, N. J. Am. Soc. Nephrol. (1994) [Pubmed]
  13. Cogwheel rigidity during chronic lithium therapy. Asnis, G.M., Asnis, D., Dunner, D.L., Fieve, R.R. The American journal of psychiatry. (1979) [Pubmed]
  14. Letter: Cogwheel rigidity in lithium therapy. Bien, R.D. The American journal of psychiatry. (1976) [Pubmed]
  15. Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease. Starr, M.S., Starr, B.S., Kaur, S. Neuroscience and biobehavioral reviews. (1997) [Pubmed]
  16. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. Harsch, H.H. The Journal of clinical psychiatry. (1987) [Pubmed]
  17. Involvement of cerulospinal glutamatergic neurotransmission in fentanyl-induced muscular rigidity in the rat. Fu, M.J., Tsen, L.Y., Lee, T.Y., Lui, P.W., Chan, S.H. Anesthesiology (1997) [Pubmed]
  18. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat. Weinger, M.B., Segal, I.S., Maze, M. Anesthesiology (1989) [Pubmed]
  19. Involvement of G(o) alpha subtype of guanine nucleotide-binding regulatory protein at the locus coeruleus in fentanyl-induced muscular rigidity in the rat. Fu, M.J., Lin, T.C., Lui, P.W., Lee, T.Y., Chan, S.H. Neurosci. Lett. (1994) [Pubmed]
  20. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. Tanii, H., Taniguchi, N., Niigawa, H., Hosono, T., Ikura, Y., Sakamoto, S., Kudo, T., Nishimura, T., Takeda, M. Brain Res. (1996) [Pubmed]
  21. An autopsy case of malignant hyperthermia. Kimura, H., Yoshida, K., Ohsawa, M., Arai, T., Tsujimura, T. Forensic Sci. Int. (1985) [Pubmed]
  22. The effect of intravenous administration of variable-dose midazolam after fixed-dose ketamine in healthy awake cats. Ilkiw, J.E., Suter, C.M., McNeal, D., Farver, T.B., Steffey, E.P. J. Vet. Pharmacol. Ther. (1996) [Pubmed]
  23. Suppression of decerebrate rigidity by phenytoin and chlorpromazine. Anderson, R.J., Raines, A. Neurology (1976) [Pubmed]
  24. Fentanyl-induced muscle rigidity in unanesthetized and ketamine- or thiopental-anesthetized rats. Lui, P.W., Lee, T.Y., Chan, S.H. Anesthesiology (1989) [Pubmed]
  25. Differential effects of prazosin and yohimbine on fentanyl-induced muscular rigidity in rats. Tsou, M.Y., Lui, P.W., Lee, T.Y., Pan, J.T., Chan, S.H. Neuropharmacology (1989) [Pubmed]
  26. Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat. Rivest, R., St-Pierre, S., Jolicoeur, F.B. Neuropharmacology (1991) [Pubmed]
  27. (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats. Lorenc-Koci, E., Wardas, J., Wolfarth, S., Pilc, A. Brain Res. (2001) [Pubmed]
  28. L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats. Konieczny, J., Ossowska, K., Schulze, G., Coper, H., Wolfarth, S. Psychopharmacology (Berl.) (1999) [Pubmed]
  29. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. Ossowska, K., Konieczny, J., Wolfarth, S., Pilc, A. Neuropharmacology (2005) [Pubmed]
  30. Extrapyramidal type rigidity in rheumatoid arthritis. Ertan, S., Fresko, I., Apaydin, H., Ozekmekçi, S., Yazici, H. Rheumatology (Oxford, England) (1999) [Pubmed]
  31. Antagonization of fentanyl-induced muscular rigidity by denervation of the coerulospinal noradrenergic pathway in the rat. Lui, P.W., Chang, G.J., Lee, T.Y., Chan, S.H. Neurosci. Lett. (1993) [Pubmed]
  32. Inhibition by neuropeptide Y of fentanyl-induced muscular rigidity at the locus coeruleus in rats. Lai, S., Lui, P. Neurosci. Lett. (2000) [Pubmed]
  33. Forces applied during laryngoscopy in children. Are volatile anaesthetics essential for suxamethonium induced muscle rigidity? Bucx, M.J., Van Geel, R.T., Meursing, A.E., Stijnen, T., Scheck, P.A. Acta anaesthesiologica Scandinavica. (1994) [Pubmed]
  34. Fatal acute poisoning by bentazon. Turcant, A., Harry, P., Cailleux, A., Puech, M., Bruhat, C., Vicq, N., Le Bouil, A., Allain, P. Journal of analytical toxicology. (2003) [Pubmed]
WikiGenes - Universities